169 related articles for article (PubMed ID: 9458204)
1. Functional disability and end organ damage in patients with systemic lupus erythematosus (SLE), SLE and Sjögren's syndrome (SS), and primary SS.
Sutcliffe N; Stoll T; Pyke S; Isenberg DA
J Rheumatol; 1998 Jan; 25(1):63-8. PubMed ID: 9458204
[TBL] [Abstract][Full Text] [Related]
2. Sjögren's syndrome associated with systemic lupus erythematosus: clinical and laboratory profiles and comparison with primary Sjögren's syndrome.
Manoussakis MN; Georgopoulou C; Zintzaras E; Spyropoulou M; Stavropoulou A; Skopouli FN; Moutsopoulos HM
Arthritis Rheum; 2004 Mar; 50(3):882-91. PubMed ID: 15022331
[TBL] [Abstract][Full Text] [Related]
3. Depressive symptoms in patients with systemic lupus erythematosus: association with central nervous system lupus and Sjögren's syndrome.
Utset TO; Golden M; Siberry G; Kiri N; Crum RM; Petri M
J Rheumatol; 1994 Nov; 21(11):2039-45. PubMed ID: 7869307
[TBL] [Abstract][Full Text] [Related]
4. Quality of life and psychological status in patients with primary Sjögren's syndrome and sicca symptoms without autoimmune features.
Champey J; Corruble E; Gottenberg JE; Buhl C; Meyer T; Caudmont C; Bergé E; Pellet J; Hardy P; Mariette X
Arthritis Rheum; 2006 Jun; 55(3):451-7. PubMed ID: 16739213
[TBL] [Abstract][Full Text] [Related]
5. Clinical, serologic, and genetic profiles of patients with associated Sjögren's syndrome and systemic lupus erythematosus.
Szanto A; Szodoray P; Kiss E; Kapitany A; Szegedi G; Zeher M
Hum Immunol; 2006 Nov; 67(11):924-30. PubMed ID: 17145372
[TBL] [Abstract][Full Text] [Related]
6. Elevated levels of soluble CD40 ligand (sCD40L) in serum of patients with systemic autoimmune diseases.
Goules A; Tzioufas AG; Manousakis MN; Kirou KA; Crow MK; Routsias JG
J Autoimmun; 2006 May; 26(3):165-71. PubMed ID: 16621447
[TBL] [Abstract][Full Text] [Related]
7. Quality of life in patients with Sjögren's syndrome and sicca complex.
López-Jornet P; Camacho-Alonso F
J Oral Rehabil; 2008 Dec; 35(12):875-81. PubMed ID: 18976259
[TBL] [Abstract][Full Text] [Related]
8. IgA and IgG autoantibodies against alpha-fodrin as markers for Sjögren's syndrome. Systemic lupus erythematosus.
Witte T; Matthias T; Arnett FC; Peter HH; Hartung K; Sachse C; Wigand R; Braner A; Kalden JR; Lakomek HJ; Schmidt RE
J Rheumatol; 2000 Nov; 27(11):2617-20. PubMed ID: 11093442
[TBL] [Abstract][Full Text] [Related]
9. [Association of systemic lupus erythematosus and Sjögren's syndrome].
Szántó A; Kiss E; Sas A; Szegedi G; Zeher M
Orv Hetil; 2005 Dec; 146(50):2533-8. PubMed ID: 16440498
[TBL] [Abstract][Full Text] [Related]
10. [Psychiatric manifestations of lupus erythematosus systemic and Sjogren's syndrome].
Ampélas JF; Wattiaux MJ; Van Amerongen AP
Encephale; 2001; 27(6):588-99. PubMed ID: 11865567
[TBL] [Abstract][Full Text] [Related]
11. Systemic lupus erythematosus with Sjögren syndrome compared to systemic lupus erythematosus alone: a meta-analysis.
Yao Q; Altman RD; Wang X
J Clin Rheumatol; 2012 Jan; 18(1):28-32. PubMed ID: 22157271
[TBL] [Abstract][Full Text] [Related]
12. Sjogren's syndrome-onset lupus patients have distinctive clinical manifestations and benign prognosis: a case-control study.
Xu D; Tian X; Zhang W; Zhang X; Liu B; Zhang F
Lupus; 2010 Feb; 19(2):197-200. PubMed ID: 19900977
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of endometriosis in women with systemic lupus erythematosus and Sjogren's syndrome.
Matorras R; Ocerin I; Unamuno M; Nieto A; Peiró E; Burgos J; Expósito A
Lupus; 2007; 16(9):736-40. PubMed ID: 17728368
[TBL] [Abstract][Full Text] [Related]
14. Neuropsychiatric syndromes in patients with systemic lupus erythematosus and primary Sjögren syndrome: a comparative population-based study.
Harboe E; Tjensvoll AB; Maroni S; Gøransson LG; Greve OJ; Beyer MK; Herigstad A; Kvaløy JT; Omdal R
Ann Rheum Dis; 2009 Oct; 68(10):1541-6. PubMed ID: 18930990
[TBL] [Abstract][Full Text] [Related]
15. Sjögren's syndrome and pregnancy.
Takaya M; Ichikawa Y; Shimizu H; Uchiyama M; Moriuchi J; Arimori S
Tokai J Exp Clin Med; 1991 Jul; 16(2):83-8. PubMed ID: 1780917
[TBL] [Abstract][Full Text] [Related]
16. Effect of disease activity and damage on quality of life in patients with systemic lupus erythematosus: a 2-year prospective study.
Mok CC; Ho LY; Cheung MY; Yu KL; To CH
Scand J Rheumatol; 2009; 38(2):121-7. PubMed ID: 18991189
[TBL] [Abstract][Full Text] [Related]
17. Anxiety and depression in patients with primary Sjögren's syndrome.
Valtýsdóttir ST; Gudbjörnsson B; Lindqvist U; Hällgren R; Hetta J
J Rheumatol; 2000 Jan; 27(1):165-9. PubMed ID: 10648034
[TBL] [Abstract][Full Text] [Related]
18. Autoantibodies against alpha-fodrin in Sjögren's syndrome with neurological manifestations.
de Seze J; Dubucquoi S; Fauchais AL; Hachulla E; Matthias T; Lefranc D; Hatron PY; Vermersch P; Witte T
J Rheumatol; 2004 Mar; 31(3):500-3. PubMed ID: 14994394
[TBL] [Abstract][Full Text] [Related]
19. Neuropsychiatric events in systemic lupus erythematosus: attribution and clinical significance.
Hanly JG; McCurdy G; Fougere L; Douglas JA; Thompson K
J Rheumatol; 2004 Nov; 31(11):2156-62. PubMed ID: 15517627
[TBL] [Abstract][Full Text] [Related]
20. Associates of health status in patients with systemic lupus erythematosus.
Sutcliffe N; Clarke AE; Levinton C; Frost C; Gordon C; Isenberg DA
J Rheumatol; 1999 Nov; 26(11):2352-6. PubMed ID: 10555890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
